CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis
from PharmaTimes: News RSS https://ift.tt/AZpVQFh
Post Top Ad
Monday, 27 June 2022
AbbVie’s Rinvoq gains recommended approval by CHMP
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment